IFP Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-438
| Closed | -$2.34K | – | 3367 |
|
|
2024
Q1 | $2.34K | Hold |
438
| – | – | ﹤0.01% | 2647 |
|
|
2023
Q4 | $3.41K | Hold |
438
| – | – | ﹤0.01% | 2535 |
|
|
2023
Q3 | $1.73K | Hold |
438
| – | – | ﹤0.01% | 2875 |
|
|
2023
Q2 | $1.38K | Hold |
438
| – | – | ﹤0.01% | 2996 |
|
|
2023
Q1 | $2.66K | Sell |
438
-355
| -45% | -$2.16K | ﹤0.01% | 2802 |
|
|
2022
Q4 | $6K | Buy |
793
+743
| +1,486% | +$5.62K | ﹤0.01% | 3740 |
|
|
2022
Q3 | $1K | Buy |
50
+45
| +900% | +$900 | ﹤0.01% | 4725 |
|
|
2022
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 4493 |
|
|
2022
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 4493 |
|
|
2021
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 3109 |
|
|
2021
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 3107 |
|
|
2021
Q2 | – | Sell |
-2
| Closed | – | – | 4527 |
|
|
2021
Q1 | $0 | Sell |
2
-9
| -82% | – | ﹤0.01% | 4391 |
|
|
2020
Q4 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 2813 |
|
|
2017
Q4 | – | Sell |
-50
| Closed | -$7K | – | 4090 |
|
|
2017
Q3 | $7K | Buy |
+50
| New | +$7K | ﹤0.01% | 3208 |
|